7.1-7.7 | 临床研究顶刊快报
文摘
教育
2024-07-08 10:08
中国香港
1. Cook D, Deane A, Lauzier F, Zytaruk N, Guyatt G, Saunders L, et al. Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation. New England Journal of Medicine. 2024;391(1):9-20.2. Riedl MA, Tachdjian R, Lumry WR, Craig T, Karakaya G, Gelincik A, et al. Efficacy and Safety of Donidalorsen for Hereditary Angioedema. New England Journal of Medicine. 2024;391(1):21-31.3. Riedl MA, Farkas H, Aygören-Pürsün E, Psarros F, Soteres DF, Staevska M, et al. Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks. New England Journal of Medicine. 2024;391(1):32-43.4. Vergote I, González-Martín A, Fujiwara K, Kalbacher E, Bagaméri A, Ghamande S, et al. Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer. New England Journal of Medicine. 2024;391(1):44-55.5. Peters NE, Lochlainn DJM, Dhalla F, Howarth L, Gupte GL, Sharif K, et al. Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema. New England Journal of Medicine. 2024;391(1):56-9.6. Spring B, Pfammatter AF, Scanlan L, Daly E, Reading J, Battalio S, et al. An Adaptive Behavioral Intervention for Weight Loss Management: A Randomized Clinical Trial. JAMA. 2024;332(1):21-30.7. Hoddinott P, O’Dolan C, Macaulay L, Dombrowski SU, Swingler J, Cotton S, et al. Text Messages With Financial Incentives for Men With Obesity: A Randomized Clinical Trial. JAMA. 2024;332(1):31-40.8. Ogedegbe G, Teresi JA, Williams SK, Ogunlade A, Izeogu C, Eimicke JP, et al. Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical Trial. JAMA. 2024;332(1):41-50.9. Meulenbeld A, Ramondt S, Sweegers MG, Quee FA, Prinsze FJ, Hoogendijk EO, et al. Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial. The Lancet. 2024;404(10447):31-43.10. Jackson TL, Desai R, Wafa HA, Wang Y, Peacock J, Peto T, et al. Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial. The Lancet. 2024;404(10447):44-54.11. Kato K, Machida R, Ito Y, Daiko H, Ozawa S, Ogata T, et al. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial. The Lancet. 2024;404(10447):55-66.部分文字参考新英格兰医学前沿。